Rituxan is currently in MS trials (for PP, SP and RR).
It was approved earlier this year for Rheumatoid Arthritis.
Phase III results for RA look good - like MS, RA was considered a T cell mediated disease but B cells also looks as if they play a role.
Let's hope that the Rituxan trials for MS show similar good results.
http://www.biogenidec.com/site/019_0.ht ... PR_133.htm